LOC645676 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.975400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.216000E-01
Normal-vs-Stage2
9.234600E-01
Normal-vs-Stage3
4.741200E-01
Normal-vs-Stage4
6.040800E-01
Stage1-vs-Stage2
3.193200E-01
Stage1-vs-Stage3
5.649700E-02
Stage1-vs-Stage4
6.989200E-01
Stage2-vs-Stage3
2.462400E-01
Stage2-vs-Stage4
4.832200E-01
Stage3-vs-Stage4
2.561000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.873800E-01
Normal-vs-AfricanAmerican
8.388400E-01
Normal-vs-Asian
4.786000E-01
Caucasian-vs-AfricanAmerican
7.555800E-01
Caucasian-vs-Asian
1.924820E-01
AfricanAmerican-vs-Asian
1.956050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.571000E-01
Normal-vs-Female
9.545000E-01
Male-vs-Female
6.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.446600E-01
Normal-vs-Age(41-60Yrs)
9.579000E-01
Normal-vs-Age(61-80Yrs)
9.720600E-01
Normal-vs-Age(81-100Yrs)
9.757600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.536000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.958400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.283400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.628400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.643600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.079000E-01
Normal-vs-Daily Drinker
8.770200E-01
Normal-vs-Weekly Drinker
8.124800E-01
Normal-vs-Occasional Drinker
7.400600E-01
Normal-vs-Social Drinker
9.050400E-01
Non Drinker-vs-Daily Drinker
5.602600E-01
Non Drinker-vs-Weekly Drinker
4.815600E-01
Non Drinker-vs-Occasional Drinker
5.478200E-01
Non Drinker-vs-Social Drinker
9.089600E-01
Daily Drinker-vs-Weekly Drinker
7.707400E-01
Daily Drinker-vs-Occasional Drinker
3.204200E-01
Daily Drinker-vs-Social Drinker
6.706200E-01
Weekly Drinker-vs-Occasional Drinker
3.125800E-01
Weekly Drinker-vs-Social Drinker
5.850000E-01
Occasional Drinker-vs-Social Drinker
7.780000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.260400E-01
Normal-vs-Grade 2
1.534840E-01
Normal-vs-Grade 3
2.074400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.081000E-01
Grade 1-vs-Grade 3
4.342000E-01
Grade 1-vs-Grade 4
3.260400E-01
Grade 2-vs-Grade 3
4.799400E-01
Grade 2-vs-Grade 4
1.534840E-01
Grade 3-vs-Grade 4
2.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.193000E-01
Normal-vs-NonDiabetic
9.036800E-01
Diabetic-vs-NonDiabetic
4.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.102600E-01
Normal-vs-NoPancreatitis
9.704600E-01
Pancreatitis-vs-NoPancreatitis
1.693640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.524200E-01
Normal-vs-N1
7.362200E-01
N0-vs-N1
1.340080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.198800E-01
Normal-vs-TP53-NonMutant
8.490400E-01
TP53-Mutant-vs-TP53-NonMutant
2.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
